Меню
Набор скоро начнётся NCT06807333

Transforming Diabetes Care: Pharmacist-Led Education and Its Impact on Patient Knowledge, Self-Management, and Health Outcomes

Без фазы С лечением Diabetes Mellitus

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Pharmacist led Education.
Кому может быть актуально
Состояния в реестре: Diabetes Mellitus. Базовые параметры: 18 лет — 60 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Пакистан
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Обзор

This interventional study is to evaluate the impact of pharmacist-led education on diabetic patients' knowledge, self-management, and overall health outcomes. Participants in this study will attend pharmacist-led educational sessions designed to improve their understanding of diabetes and self-care practices. Researchers will assess changes in patients' knowledge, self-management behaviors, and clinical health markers before and after the intervention. The study will compare pre- and post-intervention results to determine the effectiveness of pharmacist-led education in transforming diabetes care.

Подробное описание

The purpose of this study is to investigate whether pharmacist-led education can enhance the knowledge, self-management behaviors, and health outcomes of diabetic patients. Effective diabetes management requires a comprehensive understanding of the disease, adherence to lifestyle modifications, and consistent monitoring of health indicators. Poor knowledge and suboptimal self-care can lead to inadequate glycemic control, complications, and reduced quality of life. This study will evaluate the impact of pharmacist-led educational interventions on patients' motivation, diabetes-related knowledge, and self-care behaviors, as well as their effects on clinical outcomes, including improved HbA1c levels, reduced hypo- and hyperglycemic episodes, and enhanced patient satisfaction. By addressing these critical aspects, the study aims to highlight the transformative role of pharmacist-led education in advancing diabetes care and fostering sustainable, patient-centered healthcare practices.

Вмешательства

  • Поведенческое Pharmacist led Education
    Pharmacist-led education for diabetic patients focuses on enhancing their understanding of the disease, improving self-management skills, and promoting better health outcomes. The education covers key aspects of diabetes, such as the importance of blood sugar control, the role of diet and exercise, and how to monitor blood glucose levels. Patients are also taught effective self-management strategies, including how to make healthy food choices, incorporate physical activity into daily routines, a

Первичные конечные точки

  • Diabetes Knowledge Score(DKQ-24) [Срок оценки: 3 months]
  • Diabetes Management Self-Efficacy Score (DMSQ-16) [Срок оценки: 3 months]
  • HbA1C Levels (%) [Срок оценки: 3 months]

Критерии участия

Критерии включения

  • We will include all confirmed diabetic patients who visit the SIH endocrinology OPD Clinic during the study duration.
  • Both male and female patients visiting the Endocrinology Unit of the hospital will be eligible.
  • Patients with HbA1c levels greater than 8% will be included.
  • Both follow-up and newly diagnosed patients will be considered.
  • Patients who sign the informed consent form will be enrolled in the study.

Критерии исключения

  • We will exclude patients with gestational diabetes mellitus (GDM).
  • Patients with central obesity will not be included in the study.
  • Type 1 diabetes mellitus (DM) patients under the age of 20 will be excluded.
  • Patients with inadequate medical history will be excluded from participation.
  • Patients with HbA1c levels less than 8% will not be included.
  • Patients who do not provide informed consent or express a lack of interest in the study will be excluded.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Не применимо
Модель
Одна группа
Маскирование
Открытое
Основная цель
Поддерживающая терапия

Центры проведения

Пакистан · 1 центр
  • Shifa International Hospital — Islamabad

Идентификаторы

NCT: NCT06807333 · 318-24

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗